Call Us @ 0172 - 4680800 | info@indswift.com | NETWORKS | NSE - BSE

Investors

IND-SWIFT Lth.
Regd. Office: 781, Industrial Area, Phase-II, Chandigarh-160002
UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2011
(Rs. In lacs.)
PARTICULARS UNAUDITED
QUARTER
30.06.11
UNAUDITED
QUARTER
30.06.10
UNAUDITED
YEAR END
31.03.11
Net Sale/Income from operations 24043.26 17839.64 31.03.11
Other Operating Income 1364.81 2.61 57.73
Total net sale/ Operating Income 25408.07 17842.25 87618.92
Expenditure
Inc.(-)/dec.(+) in stock in trade & W.I.P. -4709.49 -1955.00 -11009.79
Consumption of raw material 23514.85 15185.00 77512.26
Employee Cost 717.58 591.46 2521.92
Depriciation/ Amortisation 440.11 375.00 1551.88
Other Expenditure 2182.97 1435.70 7389.10
Total Expenditure 22146.02 15632.16 77965.37
Profit from operations 3262.05 2210.09 9653.55
Other Income 19.82 15.21 565.25
Profit before Interest 3281.87 2225.30 10218.80
Interest 1697.53 1073.78 5797.36
Profit before tax 1584.34 1151.52 4421.44
Provision for tax 317.03 229.50 881.19
MAT Credit entitlement (317.03) (229.50) (881.19)
Provision for deffered tax 50.00 50.00 200.00
Net Profit 1534.34 1101.52 4221.44
Share Capital 843.57 782.69 843.57
E.P.S.(Rs.) 3.64 2.86 10.82
Public Shareholding
No. of Shares 23790064 22790064.00 22790064.00
% of shareholding 56.4 58.23 61.30
Promoters & Promoters group Shareholding
a) Pledged/ encumberered nil nil nil
- No. of Shares nil nil nil
-% of shares (as a % of the total shareholding of
promoter & promoter group nil nil nil
- % of shares( as a % of the total share capital of the
company nil nil nil
b) Non- Encumbered
- No. of Shares 18388306 16344306.00 14388306.00
- % of shares (as a % of the total shareholding of
promoter & promoter group 100 100.00 100.00
- % of shares( as a % of the total share capital of the
company 43.6 41.77 38.70
Notes:-

1. During the quarter under review, the net income of the comapny has increased by 42% and net profit of the company has increased by 39%as compared to same period during previous year.

2. The company is exclusively in Pharmaceutical segment.

3. Information on the Investors' Complaints fro the Quarter: Opening-Nil, Received- 7, Resolved -7, Pending-Nil
4. Previous year figures have been re-grouped/ re-arranged wherever necessary

5. The above results were taken into record by the Audir Committee and the Board of Directors of the company in their respective meetings held on August 10,2011

On behalf of the Board of Directors
Date:August 10,2011 (S.R.Mehta)